Sanguine

Sanguine

Biotechnology, 400 W Cummings Park, Woburn, Massachusetts, 01801, United States, 51-200 Employees

sanguinebio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is SANGUINE

Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridg...

Read More

map
  • 400 W Cummings Park, Woburn, Massachusetts, 01801, United States Headquarters: 400 W Cummings Park, Woburn, Massachusetts, 01801, United States
  • 2010 Date Founded: 2010
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SANGUINE

Sanguine Org Chart and Mapping

Employees

Nicole Elphic

Senior Manager, Patient Engagement

Desiree Roman

Clinical Research Coordinator

Carolyn Bidwell

Senior Research Coordinator

Jason Jung

Manager, Business Systems

Brian Vong

Associate Director, Product Marketing

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sanguine

Answer: Sanguine's headquarters are located at 400 W Cummings Park, Woburn, Massachusetts, 01801, United States

Answer: Sanguine's phone number is 85********

Answer: Sanguine's official website is https://sanguinebio.com

Answer: Sanguine's revenue is $50 Million to $100 Million

Answer: Sanguine's SIC: 2836

Answer: Sanguine's NAICS: 561110

Answer: Sanguine has 51-200 employees

Answer: Sanguine is in Biotechnology

Answer: Sanguine contact info: Phone number: 85******** Website: https://sanguinebio.com

Answer: Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridges the gap between patients and researchers through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services. Sanguine has supported translational, clinical, and cell & gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, shortening timelines and validating early-stage results to increase confidence and refine biomarkers in human trials. Four years in a row, Sanguine received the prestigious designation of a Great Places to Work company. In 2022, Sanguine was designated #2038 on the Inc. 5000 Americas Fastest Growing Private Companies list and achieved recognition on FORTUNEs 100 Best Small Workplaces and Best Workplaces in Biopharma. Referenced in over 140 publications, Sanguine studies have appeared in high-impact journals, including Science, Nature, NEJM, Nature Medicine, and Science Translational Medicine. Popular media outlets featuring Sanguine include the Fox News Channel, The Washington Post, Inc.,The Boston Globe, Inc., and many others.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access